1 recruiting, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
Follow CAR-T Cell: new trials by email Literature Review of CAR-T Cell trials Research Report on CAR-T Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients Dasatinib plus anti-CD19/CD22 CAR-T cells - Ph Positive ALL, CAR-T Cell | Phase 1 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 15 | 2021-03-01 | 2023-11-28 |
| GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers CAR-T cells targeting GPC3, Mesothelin, Claudin18.2, GUCY2C, B7-H3, PSCA, PSMA, MUC1, TGFβ, HER2, Lewis-Y, AXL, or EGFR - Lung Cancer, Cancer | Phase 1 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 30 | 2017-07-01 | 2024-06-25 |
Lung Neoplasms (1) · Neoplasms (1)
Lung Diseases (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Dasatinib (1) · Guanylate Cyclase (1) · Mesothelin (1) · PSCA protein, human (1)
Second Affiliated Hospital of Guangzhou Medical University (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (2)
Xianmin Song, M.D. (1) · Zhenfeng Zhang, MD,PhD (1)